Pages that link to "Q34610304"

The following pages link to Efficacy of infliximab in refractory pouchitis and Crohn's disease-related complications of the pouch: a Belgian case series (Q34610304):

Displaying 31 items.

• Use of Biologics in Pouchitis: A Systematic Review (Q26995117) (← links)
• Surgery and diagnostic imaging in abdominal Crohn's disease. (Q27000186) (← links)
• Synergy between intraepithelial lymphocytes and lamina propria T cells drives intestinal inflammation during infection (Q35388218) (← links)
• The Failed J Pouch (Q36940463) (← links)
• Perianal Crohn's disease: predictive factors and genotype-phenotype correlations. (Q36966103) (← links)
• Infliximab to Treat Refractory Inflammation After Pelvic Pouch Surgery for Ulcerative Colitis (Q37098456) (← links)
• Infliximab and/or Azathioprine in the Treatment of Crohn's Disease-Like Complications After IPAA (Q37821188) (← links)
• The bacterial pathogenesis and treatment of pouchitis (Q37823330) (← links)
• Transmural inflammation is not pathognomonic for Crohn's disease of the pouch (Q37887577) (← links)
• Update on anal fistulae: surgical perspectives for the gastroenterologist (Q37969124) (← links)
• Intraoperative, postoperative and reoperative problems with ileoanal pouches (Q37981627) (← links)
• Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations (Q38049779) (← links)
• The pediatric pouch in inflammatory bowel disease: a primer for the gastroenterologist (Q38085062) (← links)
• Infliximab for the treatment of pouchitis (Q38168531) (← links)
• Biological therapy for ulcerative colitis (Q38262662) (← links)
• Refractory duodenal Crohn's disease successfully treated with infliximab (Q38263174) (← links)
• One-year infliximab administration for the treatment of chronic refractory pouchitis (Q38354351) (← links)
• Crohn's Disease of the Ileoanal Pouch (Q38801703) (← links)
• Systematic review with meta-analysis: the management of chronic refractory pouchitis with an evidence-based treatment algorithm. (Q39051224) (← links)
• Successful Long-Term Use of Infliximab in Refractory Pouchitis in an Adolescent (Q42577904) (← links)
• Extended spectrum beta-lactamase-producing bacteria and Clostridium difficile in patients with pouchitis (Q42971790) (← links)
• Vedolizumab in the treatment of chronic, antibiotic-dependent or refractory pouchitis (Q47269526) (← links)
• Outcomes with Anti-Tumour Necrosis Factor-Alpha Therapy and Serology in Patients with Denovo Crohn's Disease After Ileal Pouch Anal Anastomosis (Q51227693) (← links)
• Redo Ileal pouch-anal anastomosis combined with anti-TNF-α maintenance therapy for Crohn's disease with pelvic fistula: report of two cases. (Q53636623) (← links)
• Biological therapy for the treatment of prepouch ileitis: a retrospective observational study from three centers (Q60303333) (← links)
• Infliximab in inflammatory bowel disease (Q64121962) (← links)
• Endoscopic activity in asymptomatic patients with an ileal pouch is associated with an increased risk of pouchitis (Q90451447) (← links)
• Association between serum tumor necrosis factor-alpha level and the efficacy of infliximab for refractory pouchitis after restorative proctocolectomy in patients with ulcerative colitis (Q90471929) (← links)
• Inflammatory Pouch Conditions Are Common After Ileal Pouch Anal Anastomosis in Ulcerative Colitis Patients (Q90511200) (← links)
• Pouchitis: Treatment dilemmas at different stages of the disease (Q90656409) (← links)
• Surgery and paediatric inflammatory bowel disease (Q93016378) (← links)